Annual CFI
-$138.00 M
NaN%
December 31, 2021
Summary
- As of February 10, 2025, IBER annual cash flow from investing activities is -$138.00 million
Performance
IBER Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2022
Summary
- As of February 10, 2025, IBER quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2022.
- Over the past year, IBER quarterly CFI has stayed the same.
Performance
IBER Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
September 30, 2022
Summary
- As of February 10, 2025, IBER TTM cash flow from investing activities is $0.00, unchanged on September 30, 2022.
- Over the past year, IBER TTM CFI has increased by +$138.00 million (+100.00%).
Performance
IBER TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IBER Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | 0.0% | +100.0% |
| 3 y3 years | - | +100.0% | +100.0% |
| 5 y5 years | - | +100.0% | +100.0% |
IBER Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low | at high | <-9999.0% |
| 5 y | 5-year | at high | at low | at high | <-9999.0% | at high | <-9999.0% |
| alltime | all time | at high | at low | at high | <-9999.0% | at high | <-9999.0% |
Ibere Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$138.00 M | $0.00(0.0%) | -$138.00 M(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | -$138.00 M(0.0%) |
| Jun 2021 | - | $0.00(-100.0%) | -$138.00 M(0.0%) |
| Mar 2021 | - | -$138.00 M | -$138.00 M |
FAQ
- What is Ibere Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals quarterly CFI year-on-year change?
- What is Ibere Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals TTM CFI year-on-year change?
What is Ibere Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of IBER is -$138.00 M
What is the all time high annual CFI for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high annual cash flow from investing activities is -$138.00 M
What is Ibere Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of IBER is $0.00
What is the all time high quarterly CFI for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high quarterly cash flow from investing activities is $0.00
What is Ibere Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, IBER quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Ibere Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of IBER is $0.00
What is the all time high TTM CFI for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high TTM cash flow from investing activities is $0.00
What is Ibere Pharmaceuticals TTM CFI year-on-year change?
Over the past year, IBER TTM cash flow from investing activities has changed by +$138.00 M (+100.00%)